← Eichor
Study identifier: NCT05384535 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

Condition: Prostate Cancer · Magnetic Resonance Imaging · Population at Risk  ·  Sponsor: Northwell Health

PhaseNA
Planned participants100
Who can joinMale, 40 Years to 55 Years
Healthy volunteersNo

About this study

To determine whether using bpMRI in subjects who are at high risk of developing prostate cancer in conjunction with PSA will improve prostate cancer screening protocols.

This description comes directly from the study's public registry record.

Talk to the study team

Cynthia Knauer, RN  ·  516-734-8500  ·  urologyresearch@northwell.edu

Monica Johnson  ·  516-734-8500  ·  urologyresearch@northwell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Cynthia KnauerLake Success, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05384535